10x Genomics, Inc. — Director's Dealing 2025

Feb 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2025-02-21

Reporting Person: MATEO ALAN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-21	Class A Common Stock	P	40000	$11.1393	Acquired	61691	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $11.04 to $11.2751. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate sale price.